CNB
GILD icon

Camden National Bank’s Gilead Sciences GILD Stock Holding History

Camden National Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$332K Sell
2,381
-50
-2% -$7K 0.04% 123
2025
Q4 		$298K Buy
+2,431
New +$295K 0.04% 132

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Camden National Bank's GILD Position: Q1 2026 in Review

Camden National Bank reduced its Gilead Sciences (GILD) stake by 2.1% in Q1 2026, selling an estimated $7K and leaving 2,381 shares worth $332K. The position accounts for 0.04% of the portfolio, ranked #123.

Camden National Bank first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Camden National Bank held 2,381 shares of Gilead Sciences worth $332K as of Q1 2026.
  • Camden National Bank sold 50 Gilead Sciences shares in Q1 2026, an estimated $7K.
  • Gilead Sciences made up 0.04% of Camden National Bank's portfolio in Q1 2026, its #123 holding.
  • Camden National Bank first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Camden National Bank's 13F filing for Q1 2026, filed 4 May 2026.